Inhibition of Respiratory Syncytial Virus Infections With Morpholino Oligomers in Cell Cultures and in Mice
Open Access
- 1 June 2008
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 16 (6) , 1120-1128
- https://doi.org/10.1038/mt.2008.81
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Inhibition of Foot-and-Mouth Disease Virus Infections in Cell Cultures with Antisense Morpholino OligomersJournal of Virology, 2007
- In Vitro Resistance Selection and In Vivo Efficacy of Morpholino Oligomers against West Nile VirusAntimicrobial Agents and Chemotherapy, 2007
- Antiviral Effects of Antisense Morpholino Oligomers in Murine Coronavirus Infection ModelsJournal of Virology, 2007
- Inhibition of Coxsackievirus B3 in Cell Cultures and in Mice by Peptide-Conjugated Morpholino Oligomers Targeting the Internal Ribosome Entry SiteJournal of Virology, 2006
- Inhibition of Multiple Subtypes of Influenza A Virus in Cell Cultures with Morpholino OligomersAntimicrobial Agents and Chemotherapy, 2006
- Activity and Regulation of Alpha Interferon in Respiratory Syncytial Virus and Human Metapneumovirus Experimental InfectionsJournal of Virology, 2005
- Respiratory Syncytial Virus Infection in Elderly and High-Risk AdultsNew England Journal of Medicine, 2005
- Cellular Uptake of Antisense Morpholino Oligomers Conjugated to Arginine-Rich PeptidesBioconjugate Chemistry, 2004
- Evaluation of a Live, Cold‐Passaged, Temperature‐Sensitive, Respiratory Syncytial Virus Vaccine Candidate in InfancyThe Journal of Infectious Diseases, 2000
- Cost of ribavirin therapy for respiratory syncytial virus infectionThe Journal of Pediatrics, 1995